Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Clinical improvement D60 or above · people with mild/moderate/severe/critical COVID‐19

It is very uncertain whether tociliuzumab changes clinical improvement D60 or moref compared with standard care/placebo (very low certainty).

1 finding from 1 review

Interleukin‐6 blocking agents for treating COVID‐19: a living systematic review 2023 · Cochrane Headline outcomes only
RR 1.1 [0.81, 1.48]
1 study · 97 participants
Very low